{
    "2018-08-29": [
        [
            {
                "time": "2018-08-29",
                "original_text": "Health Care Sector Update for 08/29/2018: GKOS,NVS,TLRY,JNJ,XENE",
                "features": {
                    "keywords": [
                        "GKOS",
                        "NVS",
                        "JNJ",
                        "sector update"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-29",
                "original_text": "Alcon Voluntarily Withdraws CyPass Micro-Stent from Global Market",
                "features": {
                    "keywords": [
                        "Alcon",
                        "CyPass",
                        "withdraws",
                        "glaucoma"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-08-29",
                "original_text": "European Commission Approves Novartis’s Tafinlar/Mekinist Combo",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Tafinlar",
                        "Mekinist",
                        "EU approval"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-29",
                "original_text": "Why Glaukos Corporation Stock Is Soaring Today",
                "features": {
                    "keywords": [
                        "Glaukos",
                        "soaring",
                        "stock"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-29",
                "original_text": "Novartis’s Alcon in Q2 2018",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Alcon",
                        "Q2 results"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-08-29",
                "original_text": "Glaukos Stock Up After Competitor Recalls Glaucoma Surgical Device",
                "features": {
                    "keywords": [
                        "Glaukos",
                        "competitor recall",
                        "stock up"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-29",
                "original_text": "The Daily Biotech Pulse: Assertio Settles With Purdue, Emergent Biosolutions In M&A Mix, Novartis Eye Care Unit Recalls Stent",
                "features": {
                    "keywords": [
                        "biotech",
                        "Assertio",
                        "Purdue",
                        "Novartis",
                        "recall"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-08-29",
                "original_text": "Novartis says glaucoma stent setback will not derail Alcon spin-off",
                "features": {
                    "keywords": [
                        "Novartis",
                        "glaucoma",
                        "stent",
                        "setback",
                        "Alcon spin-off"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}